Efficacy of Dihydroartemisinin for Treating Acne Vulgaris

Recruiting now · Early Phase 1

Conditions studied: Acne Vulgaris

In brief

The goal of this clinical trial is to learn if dihydroartemisinin (DHA) works to treat Acne Vulgaris in adults. The main question it aims to answer is: • Does DHA improve the acne severity by at least one grade after treatment. Researchers will treat patients who are clinically diagnosed as Acne Vulgaris to see if DHA works to alleviate the symptoms of Acne Vulgaris. Participants will: * Take DHA every day for 3 months * Visit the clinic once every month for checkups and tests

Key facts

Study ID

NCT07007078

Run by

Shanghai Zhongshan Hospital

People needed

60

Starts

2025-06-01

Expected to finish

2026-12-01

Last updated by the study team

2025-06-05

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinically diagnosed with acne vulgaris;
• For female patients, no pregnancy plans within the next 6 months.

You may not qualify if…

• Patients who have used sex hormones or other systemic medications for acne treatment within the past 3 months;
• Patients who have used topical medications for acne within the past 2 weeks;
• Pregnant or breastfeeding women;
• Patients with known severe diseases of vital organs (e.g., heart, liver, kidney) or malignancies.

Where it is running

• Zhongshan Hospital Fudan University — Shanghai, Shanghai Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.